Albuterol eMDPI DS

COMBINATION_PRODUCT2 trials

Sponsors

Teva Branded Pharmaceutical Products R&D, Inc., University of North Carolina, Chapel Hill

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Phase 4

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma

CompletedNCT03890666

Teva Branded Pharmaceutical Products R&D, Inc.Asthma

Start: 2020-10-26End: 2021-10-04Updated: 2026-03-19

Unknown Phase

Digihaler in Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT05241288

University of North Carolina, Chapel HillPulmonary Disease, Chronic Obstructive

Start: 2022-03-01End: 2023-02-13Updated: 2024-01-23